Simon Chowdhury Selected Research

Kidney Neoplasms (Kidney Cancer)

10/2016	Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer.
8/2014	A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer.
12/2013	The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer.
9/2011	Sequential FDG-PET/CT as a biomarker of response to Sunitinib in metastatic clear cell renal cancer.
9/2011	The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
1/2011	The effect of sunitinib on immune subsets in metastatic clear cell renal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon Chowdhury Research Topics

Disease

91	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 01/2010
37	Neoplasms (Cancer) 04/2024 - 02/2003
26	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2013
20	Disease Progression 12/2023 - 09/2011
15	Fatigue 12/2023 - 07/2014
15	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 08/2007
10	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 05/2015
8	Pain (Aches) 12/2023 - 05/2015
6	Exanthema (Rash) 04/2024 - 04/2018
6	Kidney Neoplasms (Kidney Cancer) 10/2016 - 01/2011
5	Hypertension (High Blood Pressure) 01/2023 - 07/2014
4	Adenocarcinoma 01/2023 - 01/2022
4	Nausea 01/2023 - 08/2014
4	Breast Neoplasms (Breast Cancer) 12/2006 - 09/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2014
2	Hypothyroidism 04/2024 - 04/2018
2	Septic Shock (Toxic Shock Syndrome) 11/2022 - 01/2022
2	Asthenia 11/2022 - 01/2022
2	Anemia 01/2022 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2018 - 01/2017
2	Back Pain (Backache) 01/2018 - 02/2016
2	Obesity 12/2016 - 09/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2014 - 04/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2007 - 08/2005
1	Weight Gain 04/2024
1	Hot Flashes 04/2024
1	Circulating Neoplastic Cells 01/2023
1	Febrile Neutropenia 01/2023
1	Neutropenia 11/2022
1	Lymphadenopathy 03/2022

Drug/Important Bio-Agent (IBA)

29	AndrogensIBA 04/2024 - 12/2011
24	enzalutamideIBA 01/2023 - 03/2014
23	apalutamideIBA 04/2024 - 04/2018
21	Hormones (Hormone)IBA 05/2024 - 09/2005
16	Docetaxel (Taxotere)FDA Link 01/2023 - 12/2013
14	Prostate-Specific Antigen (Semenogelase)IBA 12/2023 - 12/2016
12	Androgen Receptors (Androgen Receptor)IBA 02/2023 - 07/2014
10	abirateroneIBA 02/2023 - 03/2014
10	Biomarkers (Surrogate Marker)IBA 07/2021 - 09/2011
9	Abiraterone AcetateIBA 01/2023 - 01/2017
8	rucaparibIBA 01/2023 - 01/2020
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 12/2016
7	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 01/2017
6	Testosterone (Sustanon)FDA Link 04/2024 - 04/2013
5	bicalutamide (Casodex)FDA LinkGeneric 01/2023 - 02/2016
5	Prednisone (Sone)FDA LinkGeneric 11/2022 - 02/2014
5	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2012
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 01/2021
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 11/2020
4	pazopanib FDA Link 10/2021 - 10/2016
4	PlatinumIBA 01/2020 - 08/2005
4	Sunitinib (Sutent)FDA Link 10/2011 - 01/2011
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 04/2024 - 04/2013
3	antiarrhythmic peptide (AAP)IBA 10/2022 - 01/2021
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 06/2014
2	Alanine (L-Alanine)FDA Link 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2006
2	pembrolizumabIBA 10/2021 - 01/2021
2	B7-H1 AntigenIBA 01/2021 - 05/2015
2	Taxoids (Taxanes)IBA 01/2020 - 12/2018
2	cabazitaxel FDA Link 12/2018 - 12/2015
2	RadiopharmaceuticalsIBA 01/2018 - 04/2015
2	LigandsIBA 10/2016 - 10/2015
2	Radium-223IBA 04/2015 - 02/2014
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2014 - 12/2013
2	Estrogens (Estrogen)FDA Link 09/2006 - 12/2005
2	Aromatase InhibitorsIBA 12/2005 - 09/2005
2	Single-Chain AntibodiesIBA 01/2004 - 02/2003
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2023
1	InterferonsIBA 02/2023
1	AntigensIBA 01/2023
1	Androgen Antagonists (Antiandrogens)IBA 01/2023
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2023
1	taxaneIBA 01/2023
1	Flutamide (Eulexin)FDA LinkGeneric 01/2023
1	nilutamide (Nilandron)FDA Link 01/2023
1	Leukocyte Common Antigens (CD45 Antigen)IBA 01/2023
1	insulin receptor-related receptor (IRR)IBA 01/2023
1	Racemases and Epimerases (Epimerases and Racemases)IBA 01/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Poly Adenosine Diphosphate RiboseIBA 01/2023
1	Epithelial Cell Adhesion MoleculeIBA 01/2023
1	cabozantinibIBA 03/2022
1	atezolizumabIBA 03/2022
1	AntibodiesIBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022

Therapy/Procedure

73	Therapeutics 05/2024 - 08/2005
64	Castration 04/2024 - 01/2010
20	Drug Therapy (Chemotherapy) 01/2021 - 08/2005
8	Radiotherapy 02/2023 - 04/2013
7	Nephrectomy 01/2021 - 12/2008
4	Cystectomy 12/2018 - 08/2015
4	Immunotherapy 05/2016 - 08/2007
3	Aftercare (After-Treatment) 01/2023 - 01/2023
3	Duration of Therapy 01/2020 - 12/2006
2	Orchiectomy (Orchidectomy) 11/2022 - 02/2016
2	Chemoradiotherapy 04/2018 - 10/2016
1	Investigational Therapies (Experimental Therapy) 11/2023